The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Large Volume Parenteral Product Market Research Report 2024

Global Large Volume Parenteral Product Market Research Report 2024

Publishing Date : Sep, 2023

License Type :
 

Report Code : 1793117

No of Pages : 95

Ask Your Query

Synopsis

A large volume parenteral (LVP) is a unit dose container of greater than 50ml that is terminally sterilized by heat.

Global Large Volume Parenteral Product market is projected to reach US$ 15650 million in 2029, increasing from US$ 10350 million in 2022, with the CAGR of 6.1% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Large Volume Parenteral Product market research.

The large volume parenteral product market is driven by the growing demand for intravenous administration of fluids, electrolytes, and medications in healthcare settings, and the need for efficient drug delivery systems. Large volume parenteral products are sterile solutions typically administered through intravenous infusion to deliver fluids, nutrients, or medications to patients. The rise in the aging population and the prevalence of chronic diseases contribute to market growth as large volume parenteral products are crucial for various medical treatments and patient care. Moreover, advancements in manufacturing processes and the development of advanced drug delivery technologies have improved the safety and reliability of large volume parenteral products. However, the market also faces challenges, including the need for strict quality control and regulatory compliance to ensure product safety.

Additionally, addressing the cost of production and maintaining stable supply chains can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer a diverse range of large volume parenteral products, collaborate with healthcare institutions to meet specific patient needs, and address the challenges to meet the increasing demand for effective and reliable intravenous drug delivery solutions.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Large Volume Parenteral Product market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Baxter
  • Kelun Group
  • Fresenius Kabi
  • B Braun
  • SSY Group
  • CR Double-Cran
  • Otsuka
  • ICU Medical
  • Cisen Pharmaceutical
  • Renolit
  • Technoflex
  • Huaren Pharmaceutical
  • Sippex
  • Zhejiang Chimin

Segment by Type

  • Basic Infusion
  • Nutritional Infusion
  • Therapeutic Infusion

Segment by Application

  • Hospitals
  • Clinics
  • Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Large Volume Parenteral Product report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 Large Volume Parenteral Product Market Overview
1.1 Product Overview and Scope of Large Volume Parenteral Product
1.2 Large Volume Parenteral Product Segment by Type
1.2.1 Global Large Volume Parenteral Product Market Value Comparison by Type (2023-2029)
1.2.2 Basic Infusion
1.2.3 Nutritional Infusion
1.2.4 Therapeutic Infusion
1.3 Large Volume Parenteral Product Segment by Application
1.3.1 Global Large Volume Parenteral Product Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Large Volume Parenteral Product Market Size Estimates and Forecasts
1.4.1 Global Large Volume Parenteral Product Revenue 2018-2029
1.4.2 Global Large Volume Parenteral Product Sales 2018-2029
1.4.3 Global Large Volume Parenteral Product Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Large Volume Parenteral Product Market Competition by Manufacturers
2.1 Global Large Volume Parenteral Product Sales Market Share by Manufacturers (2018-2023)
2.2 Global Large Volume Parenteral Product Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Large Volume Parenteral Product Average Price by Manufacturers (2018-2023)
2.4 Global Large Volume Parenteral Product Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Large Volume Parenteral Product, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Large Volume Parenteral Product, Product Type & Application
2.7 Large Volume Parenteral Product Market Competitive Situation and Trends
2.7.1 Large Volume Parenteral Product Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Large Volume Parenteral Product Players Market Share by Revenue
2.7.3 Global Large Volume Parenteral Product Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Large Volume Parenteral Product Retrospective Market Scenario by Region
3.1 Global Large Volume Parenteral Product Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Large Volume Parenteral Product Global Large Volume Parenteral Product Sales by Region: 2018-2029
3.2.1 Global Large Volume Parenteral Product Sales by Region: 2018-2023
3.2.2 Global Large Volume Parenteral Product Sales by Region: 2024-2029
3.3 Global Large Volume Parenteral Product Global Large Volume Parenteral Product Revenue by Region: 2018-2029
3.3.1 Global Large Volume Parenteral Product Revenue by Region: 2018-2023
3.3.2 Global Large Volume Parenteral Product Revenue by Region: 2024-2029
3.4 North America Large Volume Parenteral Product Market Facts & Figures by Country
3.4.1 North America Large Volume Parenteral Product Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Large Volume Parenteral Product Sales by Country (2018-2029)
3.4.3 North America Large Volume Parenteral Product Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Large Volume Parenteral Product Market Facts & Figures by Country
3.5.1 Europe Large Volume Parenteral Product Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Large Volume Parenteral Product Sales by Country (2018-2029)
3.5.3 Europe Large Volume Parenteral Product Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Large Volume Parenteral Product Market Facts & Figures by Country
3.6.1 Asia Pacific Large Volume Parenteral Product Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Large Volume Parenteral Product Sales by Country (2018-2029)
3.6.3 Asia Pacific Large Volume Parenteral Product Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Large Volume Parenteral Product Market Facts & Figures by Country
3.7.1 Latin America Large Volume Parenteral Product Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Large Volume Parenteral Product Sales by Country (2018-2029)
3.7.3 Latin America Large Volume Parenteral Product Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Large Volume Parenteral Product Market Facts & Figures by Country
3.8.1 Middle East and Africa Large Volume Parenteral Product Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Large Volume Parenteral Product Sales by Country (2018-2029)
3.8.3 Middle East and Africa Large Volume Parenteral Product Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Large Volume Parenteral Product Sales by Type (2018-2029)
4.1.1 Global Large Volume Parenteral Product Sales by Type (2018-2023)
4.1.2 Global Large Volume Parenteral Product Sales by Type (2024-2029)
4.1.3 Global Large Volume Parenteral Product Sales Market Share by Type (2018-2029)
4.2 Global Large Volume Parenteral Product Revenue by Type (2018-2029)
4.2.1 Global Large Volume Parenteral Product Revenue by Type (2018-2023)
4.2.2 Global Large Volume Parenteral Product Revenue by Type (2024-2029)
4.2.3 Global Large Volume Parenteral Product Revenue Market Share by Type (2018-2029)
4.3 Global Large Volume Parenteral Product Price by Type (2018-2029)
5 Segment by Application
5.1 Global Large Volume Parenteral Product Sales by Application (2018-2029)
5.1.1 Global Large Volume Parenteral Product Sales by Application (2018-2023)
5.1.2 Global Large Volume Parenteral Product Sales by Application (2024-2029)
5.1.3 Global Large Volume Parenteral Product Sales Market Share by Application (2018-2029)
5.2 Global Large Volume Parenteral Product Revenue by Application (2018-2029)
5.2.1 Global Large Volume Parenteral Product Revenue by Application (2018-2023)
5.2.2 Global Large Volume Parenteral Product Revenue by Application (2024-2029)
5.2.3 Global Large Volume Parenteral Product Revenue Market Share by Application (2018-2029)
5.3 Global Large Volume Parenteral Product Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Corporation Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Large Volume Parenteral Product Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Baxter Large Volume Parenteral Product Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 Kelun Group
6.2.1 Kelun Group Corporation Information
6.2.2 Kelun Group Description and Business Overview
6.2.3 Kelun Group Large Volume Parenteral Product Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Kelun Group Large Volume Parenteral Product Product Portfolio
6.2.5 Kelun Group Recent Developments/Updates
6.3 Fresenius Kabi
6.3.1 Fresenius Kabi Corporation Information
6.3.2 Fresenius Kabi Description and Business Overview
6.3.3 Fresenius Kabi Large Volume Parenteral Product Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Fresenius Kabi Large Volume Parenteral Product Product Portfolio
6.3.5 Fresenius Kabi Recent Developments/Updates
6.4 B Braun
6.4.1 B Braun Corporation Information
6.4.2 B Braun Description and Business Overview
6.4.3 B Braun Large Volume Parenteral Product Sales, Revenue and Gross Margin (2018-2023)
6.4.4 B Braun Large Volume Parenteral Product Product Portfolio
6.4.5 B Braun Recent Developments/Updates
6.5 SSY Group
6.5.1 SSY Group Corporation Information
6.5.2 SSY Group Description and Business Overview
6.5.3 SSY Group Large Volume Parenteral Product Sales, Revenue and Gross Margin (2018-2023)
6.5.4 SSY Group Large Volume Parenteral Product Product Portfolio
6.5.5 SSY Group Recent Developments/Updates
6.6 CR Double-Cran
6.6.1 CR Double-Cran Corporation Information
6.6.2 CR Double-Cran Description and Business Overview
6.6.3 CR Double-Cran Large Volume Parenteral Product Sales, Revenue and Gross Margin (2018-2023)
6.6.4 CR Double-Cran Large Volume Parenteral Product Product Portfolio
6.6.5 CR Double-Cran Recent Developments/Updates
6.7 Otsuka
6.6.1 Otsuka Corporation Information
6.6.2 Otsuka Description and Business Overview
6.6.3 Otsuka Large Volume Parenteral Product Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Otsuka Large Volume Parenteral Product Product Portfolio
6.7.5 Otsuka Recent Developments/Updates
6.8 ICU Medical
6.8.1 ICU Medical Corporation Information
6.8.2 ICU Medical Description and Business Overview
6.8.3 ICU Medical Large Volume Parenteral Product Sales, Revenue and Gross Margin (2018-2023)
6.8.4 ICU Medical Large Volume Parenteral Product Product Portfolio
6.8.5 ICU Medical Recent Developments/Updates
6.9 Cisen Pharmaceutical
6.9.1 Cisen Pharmaceutical Corporation Information
6.9.2 Cisen Pharmaceutical Description and Business Overview
6.9.3 Cisen Pharmaceutical Large Volume Parenteral Product Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Cisen Pharmaceutical Large Volume Parenteral Product Product Portfolio
6.9.5 Cisen Pharmaceutical Recent Developments/Updates
6.10 Renolit
6.10.1 Renolit Corporation Information
6.10.2 Renolit Description and Business Overview
6.10.3 Renolit Large Volume Parenteral Product Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Renolit Large Volume Parenteral Product Product Portfolio
6.10.5 Renolit Recent Developments/Updates
6.11 Technoflex
6.11.1 Technoflex Corporation Information
6.11.2 Technoflex Large Volume Parenteral Product Description and Business Overview
6.11.3 Technoflex Large Volume Parenteral Product Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Technoflex Large Volume Parenteral Product Product Portfolio
6.11.5 Technoflex Recent Developments/Updates
6.12 Huaren Pharmaceutical
6.12.1 Huaren Pharmaceutical Corporation Information
6.12.2 Huaren Pharmaceutical Large Volume Parenteral Product Description and Business Overview
6.12.3 Huaren Pharmaceutical Large Volume Parenteral Product Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Huaren Pharmaceutical Large Volume Parenteral Product Product Portfolio
6.12.5 Huaren Pharmaceutical Recent Developments/Updates
6.13 Sippex
6.13.1 Sippex Corporation Information
6.13.2 Sippex Large Volume Parenteral Product Description and Business Overview
6.13.3 Sippex Large Volume Parenteral Product Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Sippex Large Volume Parenteral Product Product Portfolio
6.13.5 Sippex Recent Developments/Updates
6.14 Zhejiang Chimin
6.14.1 Zhejiang Chimin Corporation Information
6.14.2 Zhejiang Chimin Large Volume Parenteral Product Description and Business Overview
6.14.3 Zhejiang Chimin Large Volume Parenteral Product Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Zhejiang Chimin Large Volume Parenteral Product Product Portfolio
6.14.5 Zhejiang Chimin Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Large Volume Parenteral Product Industry Chain Analysis
7.2 Large Volume Parenteral Product Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Large Volume Parenteral Product Production Mode & Process
7.4 Large Volume Parenteral Product Sales and Marketing
7.4.1 Large Volume Parenteral Product Sales Channels
7.4.2 Large Volume Parenteral Product Distributors
7.5 Large Volume Parenteral Product Customers
8 Large Volume Parenteral Product Market Dynamics
8.1 Large Volume Parenteral Product Industry Trends
8.2 Large Volume Parenteral Product Market Drivers
8.3 Large Volume Parenteral Product Market Challenges
8.4 Large Volume Parenteral Product Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock